MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2018 International Congress

    Variation in the L-dopa motor response in pathologically confirmed Parkinson’s disease

    V. Pitz, N. Malek, K. Grosset, D. Grosset (Glasgow, United Kingdom)

    Objective: To examine the L-dopa-response (improvement in motor symptoms) in published cases of pathologically confirmed Parkinson’s disease (PD). Background: L-dopa responsiveness supports the diagnosis of…
  • 2018 International Congress

    Treatment with levodopa/carbidopa intestinal gel of advanced Parkinson’s disease patients: Bulgarian experience

    E. Chorbadzhieva (Sofia, Bulgaria)

    Objective: To evaluate the efficacy of levodopa/carbidopa intestinal gel (LCIG) on motor fluctuations, dyskinesia, parkinson symptoms and quality of life in patients with late Parkinson’s…
  • 2018 International Congress

    The effectiveness of boxing exercise in elderly patients including Parkinson’s disease patients

    N. Kawashima, M. Isogai, M. Matsuhashi, M. Komachi, H. Ikebe, A. Kumon, K. Miyashita, A. Sato, K. Hasegawa (Fujisawa, Japan)

    Objective: To clarify the effect of boxing exercise on balance, muscle strength and mobility in elderly patients with chronic disease including Parkinson’s disease (PD). Background:…
  • 2018 International Congress

    Exercise to improve upper limb function in people with Parkinson’s disease: A systematic review

    E. Proud, J. Blennerhassett, J. Tan, K. Miller, M. Morris, J. McGinley (Parkville, Australia)

    Objective: To review the effectiveness and describe the exercise parameters of interventions targeting upper limb (UL) function in people with PD. Background: Reduced fine hand…
  • 2018 International Congress

    Efficacy of combined treatment with acupunture and bee venom acupuncture for Parkinson’s disease: Double blind randomized controlled trial

    S.U. Park, H.M. Lee, S.Y. Cho, J.M. Park, C.N. Ko (Seoul, Republic of Korea)

    Objective: The aim of this study was to evaluate the efficacy of acupuncture and BVA for IPD through a sham-controlled trial. We also investigated whether…
  • 2018 International Congress

    Speech Intelligibility in Parkinson’s disease following Intensive Voice and Articulation Treatments

    G. Schulz, A. Halpern, J. Spielman, L. Ramig, I. Panzer, A. Sharpley, H. Hodges (Silver Spring, MD, USA)

    Objective: Our aim was to evaluate the impact of voice treatment (LSVT LOUD) and articulation treatment (LSVT ARTIC) on speech and consonant intelligibility in Parkinson's…
  • 2018 International Congress

    Parkinsonism in Christianson Syndrome: A Unique Presentation of a Unique Syndrome

    S. Chandra, K. Rao, A. Ghosh, J. Ray, H. Northrup, E. Stimming (Houston, TX, USA)

    Objective: Phenotypic variability in Christianson Syndrome Background: The SLC9A6 gene encodes a sodium-hydrogen exchanger-6 protein involved in endosomal trafficking. Loss-of-function variants in SLC9A6 gene have…
  • 2018 International Congress

    Swimming in PD patients with STN-DBS: A pilot exploratory study

    D. Flisar, S. Ibrulj, M. Trošt, M. Benedičič, P. Mušič, S. Korelc, K. Groleger Sršen (Ljubljana, Slovenia)

    Objective: Patients with PD frequently complain of losing abilitiy to swim. Our aim was to test the swimming abilities of our patients with bilateral STN-DBS…
  • 2018 International Congress

    Slowly progressive anti-Ca/ARHGAP26 autoantibody-associated cerebellar ataxia over 27 years without immunosuppressive treatment

    E. Schegk, I. Beiser, A. Wicki, L. Achtnichts, M. Bertschi (Aarau, Switzerland)

    Objective: To discuss a slowly progressive case of anti-Ca/ARHGAP26 autoantibody-associated cerebellar ataxia. Background: Anti-Ca/ARHGAP26 autoantibody-associated cerebellar ataxia was first identified in 2010 (1). Since then,…
  • 2018 International Congress

    Economic burden of advanced Parkinson’s disease in a national sample of elderly US Medicare beneficiaries: A prevalence-based estimate

    N. Dahodwala, P. Li, J. Jahnke, V. Ladage, P. Kandukuri, J. Zamudio, Y. Bao, Y. Jalundhwala, J. Doshi (Philadelphia, PA, USA)

    Objective: To estimate Parkinson's Disease (PD)-related health care costs in a national sample of elderly patients in the US and examine the incremental cost burden…
  • « Previous Page
  • 1
  • …
  • 216
  • 217
  • 218
  • 219
  • 220
  • …
  • 388
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Nilotinib for treating MSA: A preclinical proof of concept study
  • Life expectancy with and without Parkinson’s disease in the general population
  • An atypical and interesting feature of Parkinson´s disease
  • Patients with Essential Tremor Live Longer than their Relatives
    • Effect of marijuana on Essential Tremor: A case report
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley